Oncology Software
Elekta VMAT (Volumetric Modulated Arc Therapy) is Elekta’s next generation arc therapy technique that establishes new standards for radiation therapy treatment speed and dose reduction to the patient. With Elekta VMAT, single or multiple radiation beams sweep in uninterrupted arc(s) around the patient, dramatically speeding treatment delivery. Doctors can use Elekta VMAT with complete or partial arc(s) to reduce treatment times from the eight to twelve minutes required for “conventional” radiation therapy to as few as two minutes.
read more at http://www.elekta.com/VMAT
2010 Cancer Registry Users Meeting
Elekta will host its 2010 Cancer Registry Users Meeting Tuesday, April 20 in Palm Springs, California. The premier event for cancer registrars in town for NCRA’s 36th Annual Educational Conference, the meeting is complimentary for customers.
Taking place at the Hilton Palm Springs, the meeting will delve into topics such as new product features and enhancements, as well as what to expect for 2010 Standards in regard to METRIQ v 2.0.
Following the meeting, participants are invited to join Elekta for a customer appreciation party. Featuring live music, dancing and more, the event will be held poolside at the renowned Riviera Resort and Spa from 7-10 p.m. Admission is complimentary for meeting attendees, however registration is required. For those who would like to bring a guest, tickets will be available for $25 per person.
For additional information and to register, visit www.elekta.com/cancerregistry2010
At the 2009 American Association of Physicists in Medicine (AAPM) annual meeting, July 26-30 in Anaheim, California, We will demonstrate how our company’s comprehensive VMAT solution can help health care providers deliver superior cancer care with precision and ease.
Discover the new paradigm in VMAT planning
An advanced, clinically relevant IMRT planning system, Monaco® brings innovative concepts to the clinic that help make the planning process easier, more straightforward and clinically reliable.
New VMAT tools enable users to create arc-based treatment plans using all of the features already available in Monaco. With reduced planning time and increased clinical throughput, Monaco with VMAT optimizes single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans.
“The receipt of 510(k) clearance from the FDA for Monaco with VMAT is a significant event on the way to final release of the planning software,” said Joseph K. Jachinowski, President and CEO of Elekta North America. “The VMAT capabilities within Monaco will help clinicians choose the best treatment options available and improve quality of care.”
Optimize treatment with the market-leading oncology EMR
Built upon 15 years of development, application and innovation, MOSAIQ® 2.0 increases productivity, elevates efficiency and facilitates high-quality patient care. Complete with new connectivity, new functions and database enhancements, while preserving the user interface MOSAIQ supports the entire cancer team by uniting diverse systems and devices.
“Simple and intuitive, yet incredibly powerful, MOSAIQ 2.0 is the next major milestone in the development of oncology information systems,” said Jay Hoey, Executive Vice President of Product Creation for Elekta and CEO of Elekta Impac Software. “We’ve invested thousands of man-months of R&D and seriously advanced technology to deliver the most elegant, most comprehensive, most stable, and highest performing information product available for radiation and medical oncology.”
Distinguish yourself with the definitive VMAT delivery system
Elekta Infinity integrates the most advanced capabilities available with unmatched ease of use. The only fully integrated treatment system that allows personalization of imaging and treatment workflows, Infinity can dramatically reduce IMRT treatment sessions with the flexibility of multiple arcs to improve conformance.
“Elekta has always focused on providing highly refined tools, like Infinity, that support specific clinical objectives, yet share a common foundation in terms of imaging, planning and information management,” continues Jachinowski. “The result is a comprehensive treatment solution that frees clinicians to focus on patients, instead of the technology.”
Elekta also plans to host several education seminars and events in conjunction with the annual meeting. For additional information and registration, visit elekta.com/aapmevents .
A new private initiative quickens the pace of treatment
The number of patients waiting for treatment for cancer at the Auckland Hospital has declined sharply following the opening of the Auckland Radiation Oncology (ARO) Centre, it has been revealed. The centre’s clinical director professor Chellaraj Benjamin said more than 300 patients have been treated at the Centre since it became operational in November last year.
Prime Minister John Key officially inaugurated it on February 19. Dr Benjamin said although the incidence of cancer was high in New Zealand, a large number of people continued to ignore the symptoms and do not undergo medical examination and treatment.
“As official campaigns say, ‘Early detection is the best protection against cancer.’ “Breast cancer in women and prostate cancer in men are among the most common occurrences in New Zealand. Women should go for regular mammogram tests after they reach 45 years of age. Free check-up facilities are available at medical centres throughout the country. The ARO is another option for New Zealanders,” he said.
It is the first private radiation therapy centre in the country, established as a partnership between MercyAscot and South Cross Hospitals.
The $20 million facility, established at the MercyAscot site in Epsom, is proximate to services treating cancer including radiology, laboratory, consulting suites, chemotherapy and pharmacy, and has ample parking for patients.
Dr Benjamin said ARO has 12 qualified staff to operate the systems, in addition to two physicists and other visiting professionals.
“The state-of-the-art centre comprises the Elekta Synergy Radiation Therapy System with ‘Mosaiq’ electronic medical records, and is the first of its type in New Zealand to treat cancer,” he said.
Equipped with an Elekta Synergy Linear Accelerator, the system combines high-resolution 3D imaging and comprehensive workflow solutions to create a sophisticated Image Guided Radiation Therapy treatment.
Dr Benjamin said facilities and services at the centre will be continuously improved, with the next stage of development expected to be completed next year.
“Another bunker will be built to facilitate treatment of more patients. “The centre will shortly adopt a number of advanced radiation therapy techniques such as Intensity Modulated Radiation Therapy (IMRT) and radiation therapy to accentuate treatment times,” he said.
Elekta Virtual Clinic
The Elekta Virtual Clinic offers an easy way to explore how our solutions can help support healthcare professionals to provide the best possible care for patients.
Click here to view the Elekta Virtual Clinic
Low Bandwidth? No problem, click here to order your Elekta Virtual Clinic CD via the mail
Elekta volumetric modulated arc therapy (VMAT) is a new intensity-modulated radiation therapy (IMRT) treatment technique that combines the market’s only fully digital linear accelerator, 3D volumetric imaging, and advanced treatment planning expertise. This powerful trio delivers a treatment that improves the sparing of critical structures and healthy tissue—in dramatically shorter treatment times—all without comprising target coverage and patient safety.
Conformance. One or multiple arcs for precise dose control resulting in better avoidance of critical structures.
Speed. Dramatically shorter treatment times than current IMRT techniques.
Ultra-low Dose. Allows daily 3D volumetric imaging and fewer MUs.
More info at: http://www.elekta.com/vmat
Impac Software announced its collaboration with the National Comprehensive Cancer Network (NCCN) to license NCCN’s clinical care content to clinicians utilizing MOSAIQ®, Impac’s oncology electronic medical record (EMR).
MOSAIQ will be the first oncology EMR to embed an intelligent search engine that dynamically links to the NCCN Clinical Practice Guidelines in Oncology™. The NCCN Guidelines are used by clinicians to shape care recommendations covering 97 percent of all patients with cancer and are updated on a continual basis. The NCCN Guidelines, developed through an explicit review of evidence and recommendations from medical experts, address cancer detection, prevention and risk reduction, workup and diagnosis and treatment and supportive care.
In addition, MOSAIQ also will provide active access to the NCCN Drugs & Biologics Compendium™, which delineates uses of drugs and biologics in the care of patients with cancer, listing FDA-approved disease indications as well as off-label recommendations for use, and to the NCCN Chemotherapy Order Templates™.
“NCCN is looking forward to working with Impac Software to provide another important channel for distribution of the NCCN Guidelines,” says William T. McGivney, PhD, NCCN Chief Executive Officer. “As a result, clinicians will be provided with ready access to the best possible treatment options to improve outcomes for all patients with cancer.”
“Simplified, real-time access to NCCN’s evidence-based clinical content is expected to enhance the delivery of standardized care and improve patient safety,” says Joel Goldwein, M.D., Vice President of Medical Affairs for The Elekta Group. “Many of Impac’s customers are NCCN Member Institutions; however simplifying access to NCCN’s clinical content will significantly increase the use of NCCN Guidelines throughout Impac Software’s existing customer base, and in hundreds of cancer care centers.”
On-line image guided hypofractionation of a solitary lung metastasis using Elekta Synergy® at West China Hospital, Sichuan University, PR China
Solitary lung metastasis
A 47-year-old male previously treated for adenocarcinoma of the right upper lung presented with a metastasis in the lingua segment of the left upper lobe in March 2006. The metastasis was diagnosed using a contrast enhanced CT scan. The patient was evaluated and elected to proceed with a course of image guided hypofractionated stereotactic radiation therapy. The patient was first diagnosed as having a low-differentiated adenocarcinoma of the right upper lobe of the lung (stage IIIA) in March 2004 with the primary tumor in the upper apical-posterior segment of the right lung, right hilum, and an upper mediastinal lymph node metastasis. The patient was treated with right upper lung lobectomy and mediastinal lymph node dissection followed by adjuvant alternate chemotherapy (vinorelbine 40mg iv drip, days one and eight, cisplatin 50mg, IV drip, days one to three – 21 days per cycle for a total of four cycles) and radiation therapy.
View the entire case study here
To view more case studies, click here
Treatment of a right upper lobe lung tumor using Active Breathing Coordinator™ in a patient with severe pulmonary insufficiency at Centre Régional, Léon-Bérard, Lyon, France –
A 68-year-old male, former smoker, presented with a long history of severe pulmonary insufficiency, which had been managed for several years with oxygen therapy. More recently, as his pulmonary function improved the oxygen therapy was stopped.
Right upper lobe lung tumor
A recent radiograph showed a 4cm diameter tumor in the right upper lobe. CT-scan confirmed a solid mass 48 x 42mm in right upper lobe, with suspicious infra-cranial nodes (between 15 and 20mm in diameter). A PET scan showed a fixed primary tumor but a mobile mediastinum. Cranial CT and abdominal CT were normal. The tumor was considered as stage T2-3 N0-M0.
Click here for the Full Case Study
For more case studies click here
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012Russia’s first Leksell Gamma Knife® Perfexion™ system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow’s Red Square. On June 2, 2011, a 59-year-old woman was the first Perfexion patient, receiving Gamma Knife® radiosurgery to treat tumor tissue that remained following open surgery. Now, eight mon […]
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012N.N. Burdenko Neurosurgical Institute improves treatment of patients with multiple metastasesRead more... […]
- SRT January 31, 2012Würzburg10-11 December - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim26-27 November - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim22-23 November - 2012 […]
- IGRT January 31, 2012Amsterdam16-17 November - 2012 […]
- SBRT January 31, 2012Wake Forest, North Carolina18-19 October - 2012 […]
- IGRT January 31, 2012Amsterdam29-30 June - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim21-22 June - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim18-19 June - 2012 […]